Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 319

1.

Potential of old-generation antibiotics to address current need for new antibiotics.

Falagas ME, Grammatikos AP, Michalopoulos A.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):593-600. doi: 10.1586/14787210.6.5.593. Review.

PMID:
18847400
2.

Old antibiotics for infections in critically ill patients.

Falagas ME, Kopterides P.

Curr Opin Crit Care. 2007 Oct;13(5):592-7. Review.

PMID:
17762241
3.

[Side effects of antibiotic therapy (review of the literature)].

Solov'ev VN, Berezhinskaia VV.

Vopr Okhr Materin Det. 1974 Sep;19(9):63-9. Review. Russian. No abstract available.

PMID:
4370853
4.

Role of old antibiotics in multidrug resistant bacterial infections.

Maviglia R, Nestorini R, Pennisi M.

Curr Drug Targets. 2009 Sep;10(9):895-905. Review.

PMID:
19799544
5.

[Miscellaneous antibiotics].

Sawae Y.

Nihon Rinsho. 1990 Oct;48(10):2200-4. Japanese. No abstract available.

PMID:
2280465
6.

Do we still need the aminoglycosides?

Durante-Mangoni E, Grammatikos A, Utili R, Falagas ME.

Int J Antimicrob Agents. 2009 Mar;33(3):201-5. doi: 10.1016/j.ijantimicag.2008.09.001. Epub 2008 Oct 30. Review.

PMID:
18976888
7.

Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.

Roussos N, Karageorgopoulos DE, Samonis G, Falagas ME.

Int J Antimicrob Agents. 2009 Dec;34(6):506-15. doi: 10.1016/j.ijantimicag.2009.08.013. Epub 2009 Oct 13. Review.

PMID:
19828298
8.

Fusidic acid: new opportunities with an old antibiotic.

Anderson JD.

Can Med Assoc J. 1980 Apr 5;122(7):765-9. Review.

9.
10.

Other antibiotics.

Hayashi K.

Clin Orthop Relat Res. 1984 Nov;(190):109-13. Review.

PMID:
6386254
11.

Old and new targets of antibacterial therapy.

Dbaibo GS.

J Med Liban. 2000 Jul-Aug;48(4):177-81. Review.

PMID:
11214186
12.

Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis.

Rahal JJ, Simberkoff MS.

Ann Intern Med. 1982 Apr;96(4):468-74. Review.

PMID:
7039444
13.

The tide of antimicrobial resistance and selection.

Wilcox MH.

Int J Antimicrob Agents. 2009 Aug;34 Suppl 3:S6-10. doi: 10.1016/S0924-8579(09)70550-3. Review.

PMID:
19596111
14.

What's new on the antimicrobial horizon?

Song JH.

Int J Antimicrob Agents. 2008 Dec;32 Suppl 4:S207-13. doi: 10.1016/S0924-8579(09)70004-4. Review.

PMID:
19134521
15.

Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.

Hainrichson M, Nudelman I, Baasov T.

Org Biomol Chem. 2008 Jan 21;6(2):227-39. doi: 10.1039/b712690p. Epub 2007 Oct 9. Review.

PMID:
18174989
16.

[Antibiotics].

Ono Y.

Nihon Rinsho. 2012 Aug;70 Suppl 6:131-9. Japanese. No abstract available.

PMID:
23156498
17.

[Aminoglycosides and polymyxins].

Molina J, Cordero E, Palomino J, Pachón J.

Enferm Infecc Microbiol Clin. 2009 Mar;27(3):178-88. doi: 10.1016/j.eimc.2009.02.001. Review. Spanish.

PMID:
19303668
18.

Trimethoprim-sulfamethoxazole revisited.

Masters PA, O'Bryan TA, Zurlo J, Miller DQ, Joshi N.

Arch Intern Med. 2003 Feb 24;163(4):402-10. Review.

PMID:
12588198
19.

[Colimycin: an old antibiotic which has to be learnt to know].

Cohen R.

Arch Pediatr. 2010 Sep;17 Suppl 4:S171-6. doi: 10.1016/S0929-693X(10)70920-9. French.

PMID:
20826327
20.

Antibiotic use: present and future.

Zinner SH.

New Microbiol. 2007 Jul;30(3):321-5. Review.

Supplemental Content

Support Center